Related Experiment Videos
[Infectious aspects of Wegener's granulomatosis]
1Klinik für Hals-, Nasen- und Ohrenkrankheiten, Hals- und Gesichtschirurgie, Kantonsspital Luzern.
Schweizerische Medizinische Wochenschrift
|January 6, 2001
Summary
Treating chronic nasal Staphylococcus aureus carriage with cotrimoxazole may reduce Wegener
Area of Science:
- Rheumatology and Otolaryngology
- Infectious Disease Epidemiology
Background:
- Wegener's granulomatosis (WG) frequently presents in the upper respiratory tract, involving ENT specialists in early diagnosis.
- Chronic nasal carriage of Staphylococcus aureus is hypothesized to trigger relapses in WG patients.
- Targeting S. aureus nasal carriage may reduce WG relapse rates in patients in remission.
Observation:
- A case report details a 49-year-old male experiencing his second WG relapse.
- This patient underwent prolonged treatment with cotrimoxazole.
Findings:
- Prolonged cotrimoxazole therapy demonstrated a positive effect in the WG patient.
- Treatment allowed for a reduction in the dosage of cyclophosphamide and glucocorticoids.
- This reduction mitigates potential long-term side effects associated with systemic immunosuppressants.
Implications:
- Long-term cotrimoxazole treatment may decrease relapse frequency in chronic WG.
- This approach could enable reduced reliance on high-dose immunosuppressive therapies.
- Further research into S. aureus eradication strategies for WG management is warranted.